Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Pancreatic Cancer
Wungki Park, Akhil Chawla, Eileen M. O’Reilly
JAMA (2021) Vol. 326, Iss. 9, pp. 851-851
Open Access | Times Cited: 1126

Showing 101-125 of 1126 citing articles:

Ultra-sensitive CTC-based liquid biopsy for pancreatic cancer enabled by large blood volume analysis
Nikolas H. Stoecklein, Georg Fluegen, Rosa Guglielmi, et al.
Molecular Cancer (2023) Vol. 22, Iss. 1
Open Access | Times Cited: 19
Qingyihuaji Formula promotes apoptosis and autophagy through inhibition of MAPK/ERK and PI3K/Akt/mTOR signaling pathway on pancreatic cancer in vivo and in vitro
Xiang Qian, Qianyu Bi, Zeng-Na Wang, et al.
Journal of Ethnopharmacology (2023) Vol. 307, pp. 116198-116198
Closed Access | Times Cited: 18
The role of epithelial-mesenchymal transition and autophagy in pancreatic ductal adenocarcinoma invasion
Jian Yang, Ying Liu, Shi Liu
Cell Death and Disease (2023) Vol. 14, Iss. 8
Open Access | Times Cited: 18
The Potent G-Quadruplex-Binding Compound QN-302 Downregulates S100P Gene Expression in Cells and in an In Vivo Model of Pancreatic Cancer
Ahmed A. Ahmed, William Greenhalf, Daniel H. Palmer, et al.
Molecules (2023) Vol. 28, Iss. 6, pp. 2452-2452
Open Access | Times Cited: 17
Metastatic Pancreatic Cancer: Where Are We?
Abraham Hernández-Blanquisett, Valeria Quintero-Carreño, María Cristina Martínez‐Ávila, et al.
Oncology Reviews (2024) Vol. 17
Open Access | Times Cited: 7
Pro-Inflammatory Food, Gut Microbiota, and Cardiovascular and Pancreatic Diseases
Bing Chen, Shriraj Patel, Lingyu Bao, et al.
Biomolecules (2024) Vol. 14, Iss. 2, pp. 210-210
Open Access | Times Cited: 7
Pancreatic cancer biomarkers: A pathway to advance in personalized treatment selection
Elena Brozos-Vázquez, Marta Toledano‐Fonseca, Nicolás Costa‐Fraga, et al.
Cancer Treatment Reviews (2024) Vol. 125, pp. 102719-102719
Open Access | Times Cited: 7
Causal effect of gut microbiota on pancreatic cancer: A Mendelian randomization and colocalization study
Xin Li, Zhihai Liang
Journal of Cellular and Molecular Medicine (2024) Vol. 28, Iss. 8
Open Access | Times Cited: 7
Prognostic value of deep learning-derived body composition in advanced pancreatic cancer—a retrospective multicenter study
Julius Keyl, Andreas Bucher, Friederike Jungmann, et al.
ESMO Open (2024) Vol. 9, Iss. 1, pp. 102219-102219
Open Access | Times Cited: 6
CSNK2A1 confers gemcitabine resistance to pancreatic ductal adenocarcinoma via inducing autophagy
Zhide Liu, Yin-Hao Shi, Qiong‐Cong Xu, et al.
Cancer Letters (2024) Vol. 585, pp. 216640-216640
Open Access | Times Cited: 6
Uncovering the clinicopathological features of early recurrence after surgical resection of pancreatic cancer
Hye Yeon Chon, Hee Seung Lee, You‐Na Sung, et al.
Scientific Reports (2024) Vol. 14, Iss. 1
Open Access | Times Cited: 6
Implementation of Best Practices in Pancreatic Cancer Care in the Netherlands
Tara M. Mackay, Anouk E.J. Latenstein, Simone Augustinus, et al.
JAMA Surgery (2024) Vol. 159, Iss. 4, pp. 429-429
Open Access | Times Cited: 6
Use of Oleuropein and Hydroxytyrosol for Cancer Prevention and Treatment: Considerations about How Bioavailability and Metabolism Impact Their Adoption in Clinical Routine
Francesco Gervasi, Fanny Pojero
Biomedicines (2024) Vol. 12, Iss. 3, pp. 502-502
Open Access | Times Cited: 6
The Global Burden of Early-Onset Pancreatic Cancer and Its Risk Factors
Pojsakorn Danpanichkul, Kanokphong Suparan, Aunchalee Jaroenlapnopparat, et al.
Pancreas (2024) Vol. 53, Iss. 5, pp. e434-e444
Closed Access | Times Cited: 6
Glycolysis and tumor progression promoted by the m6A writer VIRMA via m6A-dependent upregulation of STRA6 in pancreatic ductal adenocarcinoma
Kege Yang, Ziyi Zhong, Jinmao Zou, et al.
Cancer Letters (2024) Vol. 590, pp. 216840-216840
Closed Access | Times Cited: 6
ECM1 and KRT6A are involved in tumor progression and chemoresistance in the effect of dexamethasone on pancreatic cancer
Yoshiki Shinomiya, Yusuke Kouchi, Sakurako Harada‐Kagitani, et al.
Cancer Science (2024) Vol. 115, Iss. 6, pp. 1948-1963
Open Access | Times Cited: 6
Cellular collusion: cracking the code of immunosuppression and chemo resistance in PDAC
Chiara Musiu, Francesca Lupo, Antonio De Agostini, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 6
Unraveling the gut microbiome’s contribution to pancreatic ductal adenocarcinoma: mechanistic insights and therapeutic perspectives
Eileen Tabrizi, Fatemeh Pourteymour Fard Tabrizi, Gehad Mahmoud Khaled, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 6
Eupalinolide B suppresses pancreatic cancer by ROS generation and potential cuproptosis
Qingtian Huang, Jie Yang, Jiaxing Zhang, et al.
iScience (2024) Vol. 27, Iss. 8, pp. 110496-110496
Closed Access | Times Cited: 6
Cellular and molecular mechanisms of gastrointestinal cancer liver metastases and drug resistance
Daosong Dong, Yu Xue, Jingjing Xu, et al.
Drug Resistance Updates (2024) Vol. 77, pp. 101125-101125
Closed Access | Times Cited: 6
Pancreatic stellate cells exploit Wnt/β-catenin/TCF7-mediated glutamine metabolism to promote pancreatic cancer cells growth
Hangqi Liu, Hui Zhang, Xiaoqian Liu, et al.
Cancer Letters (2022) Vol. 555, pp. 216040-216040
Closed Access | Times Cited: 27
Static and Dynamic68Ga-FAPI PET/CT for the Detection of Malignant Transformation of Intraductal Papillary Mucinous Neoplasia of the Pancreas
Matthias Lang, Anna-Maria Spektor, Thomas Hielscher, et al.
Journal of Nuclear Medicine (2022) Vol. 64, Iss. 2, pp. 244-251
Open Access | Times Cited: 25
Mitophagy-Related Gene Signature for Prediction Prognosis, Immune Scenery, Mutation, and Chemotherapy Response in Pancreatic Cancer
Zewei Zhuo, Hanying Lin, Jun Liang, et al.
Frontiers in Cell and Developmental Biology (2022) Vol. 9
Open Access | Times Cited: 24
Subtyping for pancreatic cancer precision therapy
Xing Huang, Gang Zhang, Tingbo Liang
Trends in Pharmacological Sciences (2022) Vol. 43, Iss. 6, pp. 482-494
Closed Access | Times Cited: 24
Molecular heterogeneity and commonalities in pancreatic cancer precursors with gastric and intestinal phenotype
Sven‐Thorsten Liffers, Laura Godfrey, Lisa Frohn, et al.
Gut (2022) Vol. 72, Iss. 3, pp. 522-534
Open Access | Times Cited: 24

Scroll to top